原发性高血压合并持续性心房颤动患者临床特征分析
CSTR:
作者:
作者单位:

(1.中国人民解放军总医院第六医学中心心血管病医学部,北京100037;2.解放军医学院,北京100853;3.南开大学医学院临床医学系,天津300071)

作者简介:

通讯作者:

中图分类号:

基金项目:

首都卫生发展科研专项项目(CSH2022-1G-5071);北京市海淀区卫生健康发展科研培育计划(HP-2021-03-80602)


Clinical characteristics of patients with essential hypertension complicated with persistent atrial fibrillation
Author:
Affiliation:

(1.Department of Cardiology, The Sixth Medical Center, Chinese PLA General Hospital, Beijing 100037, China;2.Chinese PLA Medical School, Beijing 100853, China;3.Department of Clinical Medicine, School of Medicine, Nankai University, Tianjin 300071, China)

Fund Project:

This work was supported by the Capital Funds for Health Improvement and Research(CSH2022-1G-5071)and the Hygiene and Health Development Scientific Research FosteringPlan of Haidian District of Beijing(HP-2021-O3-8O602).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨原发性高血压合并持续性心房颤动(EHP-PeAF)患者的临床特征。方法 回顾性分析2010年1月至2019年12月于解放军总医院心血管内科及神经内科住院的384例EHP-PeAF患者的临床资料。根据年龄,将患者分为≤50岁组17例、50~60岁组59例、60~70岁组108例、70~80岁组144例及>80岁组56例。根据CHA2DS2-VASc评分四分位数,将患者分为Q1组43例(≤1分)、Q2组131例(2~3分)、Q3组71例(4分)及Q4组139例(5~9分)。分析患者人口学特征、实验室指标、共病及用药情况,比较不同性别、年龄及CHA2DS2-VASc评分组间指标的差异。采用R4.5.2统计软件进行数据分析。根据数据类型,两组间比较分别采用独立样本t检验、Mann-Whitney U检验、χ2检验或Fisher确切概率法,多组间两两比较采用Bonferroni法校正。有序分类变量的趋势分析采用Cochran-Armitage趋势检验。结果 本研究患者年龄中位数为71.00(63.00,77.00)岁,体质量指数(BMI)平均数(26.21±3.86)kg/m2,男性占比62.00%,有吸烟史者占比38.50%,有饮酒史者占比38.00%。性别分层分析显示,女性患者年龄、CHA2DS2-VASc评分、高密度脂蛋白胆固醇、D二聚体及冠心病(CAD)患病率均高于男性,身高、体质量、BMI、丙氨酸氨基转移酶、肌酐、血红蛋白及尿酸水平均低于男性,差异均有统计学意义(均P<0.05)。共病方面,CAD患病率最高(66.40%),其次为心力衰竭(HF,38.30%)和脑卒中(CS,32.80%);CAD、HF、CS及外周血管疾病(PAD)患病率随年龄增长呈显著上升趋势(均P for trend<0.05),且CAD在年龄70~80岁及>80岁组患病率显著高于年龄≤50岁组(P<0.005);HF、糖尿病、CS、CAD、慢性肾脏病及PAD患病率均随CHA2DS2-VASc评分升高显著递增(均P for trend<0.005),且高评分组多重共病负荷显著高于低评分组。用药方面,52.10%的患者至少使用1种降压药,其中单药治疗151例(39.30%),≥2种联合用药49例(12.80%);钙离子通道阻滞剂为临床最常用降压药物,使用率达31.50%,其次为血管紧张素Ⅱ受体拮抗剂(20.60%),口服抗凝药(OAC)使用率仅7.30%,降压及抗凝规范化治疗均存在明显不足;OAC使用率随年龄增长呈显著上升趋势,其他降压药使用率随年龄增长呈显著下降趋势(P for trend=0.024、0.012);利尿剂用药率随CHA2DS2-VASc评分升高呈上升趋势(P for trend=0.047),而OAC使用率未得到明显提升。结论 EHP-PeAF患者心血管共病高发,抗凝与降压治疗均不足,临床需规范药物治疗并加强对共病的综合管理。

    Abstract:

    Objective To investigate the clinical characteristics of patients with essential hypertension complicated with persistent atrial fibrillation (EHP-PeAF). Methods A retrospective analysis was conducted of the clinical data of 384 EHP-PeAF patients who were hospitalized in the Department of Cardiology and Neurology of the Chinese PLA General Hospital from January 2010 to December 2019. Based on age, the patients were divided into five groups:≤50 years (n=17), 50-60 years (n=59), 60-70 years (n=108), 70-80 years (n=144), and >80 years (n=56). The patients were also divided into quartiles based on the CHA2DS2-VASc score:Q1 group (≤1 point, n=43), Q2 group (2-3 points, n=131), Q3 group (4 points, n=71), and Q4 group (5-9 points, n=139). The demographic characteristics, laboratory indicators, comorbidities, and medication use were analyzed, and the patients were compared in gender, age, and CHA2DS2-VASc score. Data analysis was performed using R 4.5.2 statistical software. Comparisons between two groups were conducted using independent sample t tests, Mann-Whitney U tests, χ2 tests, or Fisher′s exact probability method, and pairwise comparisons among multiple groups were corrected using the Bonferroni method. Trend analysis of ordinal categorical variables was performed using the Cochran-Armitage trend test. Results The median age of the patients was 71.00 (63.00,77.00) years, the average body mass index (BMI) was (26.21±3.86) kg/m2,62.00% patients were male , 38.50%had a history of smoking, and 38.00% had a history of drinking. Gender-stratified analysis showed that female patients had higher age, CHA2DS2-VASc score, high-density lipoprotein cholesterol, D-dimer, and prevalence of coronary artery disease (CAD) than male patients. Height, Body weight, BMI, alanine aminotransferase, creatinine, hemoglobin, and uric acid levels were lower in female patients, and the differences were statistically significant (all P<0.05). Among comorbidities, the prevalence of CAD was the highest (66.40%), followed by heart failure (HF, 38.30%) and stroke (CS, 32.80%). The prevalence of CAD, HF, CS, and peripheral arterial disease (PAD) increased significantly with age (all P for trend <0.05), and the prevalence of CAD in the 70-80 years and >80 years groups was significantly higher than that in ≤50 years group (P<0.005). The prevalence of HF, diabetes mellitus, CS, CAD, chronic kidney disease, and PAD increased significantly with the increase in CHA2DS2-VASc score (all P for trend <0.005), and the multiple comorbidity burden in the high-score group was significantly higher than that in the low-score group. In terms of medication use, 52.10% of the patients used at least one antihypertensive drug, including 151 patients (39.30%) on monotherapy and 49 (12.80%) on combine therapy (≥2 medications). Calcium channel blockers were the most commonly used antihypertensive drugs (31.50%), followed by angiotensin Ⅱ receptor blocker (20.60%). The usage rate of oral anticoagulant (OAC) was only 7.30%, indicating significant insufficiency in both antihypertensive and anticoagulant standardized treatment. OAC usage rate increased significantly with age, and the usage rates of other antihypertensive drugs decreased significantly with age (P for trend=0.024,0.012). The usage rate of diuretics increased with the increase in CHA2DS2-VASc score (P for trend=0.047), while OAC usage rate did not significantly increase. Conclusion EHP-PeAF patients have a high incidence of cardiovascular comorbidities and receive insufficient anticoagulation and antihypertensive treatments. Clinically, it is necessary to standardize drug therapy and strengthen comprehensive management of comorbidities.

    参考文献
    相似文献
    引证文献
引用本文

白嘉琪,李睿哲,朱梅,张明蕾,尹娜娜,李宗斌.原发性高血压合并持续性心房颤动患者临床特征分析[J].中华老年多器官疾病杂志,2026,25(7):486-492
DOI:10.11915/j. issn.1671-5403.2026.07.100

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-07-17
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-08-05
  • 出版日期:
文章二维码